评估单期采集成像联合双相静脉造影剂注射CT方案用于同期胰肾移植术后并发症的检查
本研究为实践审核,纳入2015年6月至12月连续接受CT检查以排除同期胰肾移植术后腹腔感染的10例患者共13次CT检查,采用单期采集联合双相静脉造影剂注射方案(66 ml以1.2 ml/s后接34 ml以2.4 ml/s,370 mg碘/ml,注射开始后70秒采集)。移植胰腺动脉平均衰减值均>211 HU(肠系膜上动脉259.0±51.4 HU,脾动脉245.3±37.5 HU),静脉均>80 HU(肠系膜上静脉195.4±36.2 HU,脾静脉185.1±54.2 HU),确认诊断质量合格。结论认为该单期CT方案可获得诊断质量的CT检查,可能减少患者辐射暴露,同时允许同步评估实质与血管并发症。
要点
- 单期采集于双相注射开始后70秒启动,可同时评估移植胰腺实质与血管并发症。
- 诊断质量以移植胰腺动脉血衰减值>211 HU、静脉>80 HU为确认标准。
- 动脉平均衰减值:肠系膜上动脉259.0±51.4 HU,脾动脉245.3±37.5 HU。
核心结论
- 采用单期采集联合双相静脉造影剂注射的CT方案可获得诊断质量的CT检查,可能减少患者辐射暴露,同时允许同步评估同期胰肾移植术后实质与血管并发症。
研究设计与样本
- 实践审核,纳入了2015年6月至12月连续接受CT检查以排除同期胰肾移植术后腹腔感染的10例患者共13次CT检查,无需知情同意。
关键影像表现/征象
- 移植胰腺动脉血衰减值均>211 HU:肠系膜上动脉259.0±51.4 HU,脾动脉245.3±37.5 HU。
- 移植胰腺静脉血衰减值均>80 HU:肠系膜上静脉195.4±36.2 HU,脾静脉185.1±54.2 HU。
- 排除的CT检查包括完全性胰腺坏死,以及移植肠系膜上动脉血栓伴胰头缺血导致移植肠系膜上静脉受压消失。
诊断标准与关键数值
- 诊断质量确认标准:移植胰腺动脉血衰减值>211 HU且静脉血衰减值>80 HU。
- 造影剂注射方案:双相注射,先以1.2 ml/s注射66 ml,再以2.4 ml/s注射34 ml,浓度370 mg碘/ml。
- 单期腹部和盆腔CT采集于双相造影剂注射开始后70秒启动。
临床应用与阅片要点
- 采用单期采集联合双相静脉造影剂注射方案,可在一次采集内同步评估移植胰腺实质与血管并发症。
- 阅片时需识别并测量移植胰腺命名血管内的血液衰减值,以确认诊断质量达标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the use of a single-pass with biphasic intravenous contrast medium injection computed tomography (CT) protocol to provide diagnostic quality CT studies for the assessment of complications post-simultaneous pancreas-kidney transplant (SPK).
MATERIALS AND METHODS: This was an audit of practice and the need for informed consent was waived. The protocol was used in consecutive patients undergoing CT to exclude intra-abdominal sepsis post-SPK between June and December 2015. Single CT acquisition of the abdomen and pelvis was initiated 70 seconds after the start of biphasic contrast medium injection (66 ml at 1.2 ml/s, followed by 34 ml at 2.4 ml/s, 370 mg iodine/ml). The named transplant pancreas vessels were identified and the attenuation values of the blood within were measured. Diagnostic quality was confirmed if values were >211 HU and >80 HU in the arteries and veins, respectively.
RESULTS: Thirteen CT studies were performed in 10 patients. CT studies were excluded due to complete pancreatic necrosis, and transplant superior mesenteric artery (SMA) thrombus with pancreatic head ischaemia causing effacement of the transplant superior mesenteric vein (SMV). Diagnostic quality of the analysed CT studies were confirmed with mean attenuation value of blood >211 HU in the transplant pancreatic arteries (SMA=259.0±51.4 HU, splenic artery=245.3±37.5 HU), and >80 HU in the pancreatic veins (SMV=195.4±36.2 HU, splenic vein=185.1±54.2 HU).
CONCLUSION: Diagnostic quality CT studies were obtained using the single-pass CT protocol. Radiation exposure to patients may be reduced with this protocol, while permitting simultaneous assessment of parenchymal and vascular complications post-SPK.
引用
- Chung DY, Anderson EM. Evaluation of a single-pass with biphasic intravenous contrast medium injection CT protocol for the assessment of complications post-simultaneous pancreas-kidney transplant. Clin Radiol. 2018. PMID: 29625745. doi:10.1016/j.crad.2018.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。